Related to this topic: Leaflets | Patient+ | UK Guidelines | Weblinks | Equipment | Books | Your Experience | Other resources | Glossaries
Print options: Printer friendly version of this leaflet (html)     Other options:  AddThis Social Bookmark Button (what's this?)

PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.

Scarlet Fever

Synonyms: scarlatina, scarlatinella

Scarlet fever was known as Scarlatina until 1869. It is an exotoxin-mediated disease arising from a specific bacterial infection. The infection is caused by an erythrogenic toxin-producing strain of Streptococcus pyogenes (a group A beta-haemolytic streptococcus). In most cases scarlet fever evolves from a tonsillar or pharyngeal infection but the rash develops in less than 10% of so called "strep throats". Scarlet fever can follow infection at other sites, including wounds, burns and postnatally (for example surgical scarlet fever and puerperal scarlet fever).

Pathophysiology1,2
  • Streptococci are gram-positive cocci that grow in chains. They are classified according to differences in cell wall constituents (Group A) and ability to produce haemolysis on blood agar. Beta-haemolysis implies there is complete haemolysis on agar.
  • Group A streptococci are normally found in the nasopharynx but can cause disease, for example, pharyngitis, skin infections and pneumonia.
  • Scarlet fever is associated with pharyngitis and only rarely with infection at other sites. Up to about 10% of group A streptococcal sore throats will go on to cause scarlet fever.
  • Group A beta-haemolytic streptococci secrete a variety of haemolysing enzymes and toxins including the erythrogenic toxins causing the characteristic rash of scarlet fever.
  • Person to person spread is mainly by respiratory droplets. The incubation is typically 2 to 4 days but ranges from 12 hours to 7 days.
  • Patients are contagious both during the acute illness and the initial subclinical stage. Advice on exclusion from school is variable (see Prevention below).
Epidemiology1,2,3
  • Scarlet fever is no longer implicated in the deadly epidemics of the 1800s when the death rate from scarlet fever was as high as 150/ 100,000. Complications, case mortality and incidence have fallen dramatically because of antibiotics, enhanced immunity and improved socioeconomic conditions.4 There are still sporadic outbreaks.5
  • There has been a marked reduction in the incidence of scarlet fever over the last 10 years. Notifications have fallen from about 2000 per quarter to 1000 per quarter.6 There have been similar reductions in other countries.7
  • Infection usually affects children (peak between age 4 and 8 years). However it is unusual under age 2 years because of maternal antibodies to the exotoxin and lack of prior sensitisation.
  • The infection rate increases with overcrowding and close contact. School populations have a higher incidence.
  • Incidence decreases in adults as immunity develops.
  • Infection occurs throughout the year but pharyngitis occurs most often in school age children in spring and winter.
  • Geographically skin infections caused by streptococcal organisms are more common in warmer climates and in the warmer months.
Presentation
  • Incubation is 2 to 4 days (range 12 hours to 7 days). Onset of the illness is usually sudden with fever. The rash follows 12-48 hours after the fever.
  • Often prodrome of sore throat, fever, headache, vomiting, abdominal pain, myalgia. Tachycardia accompanies the fever.
  • Scarlatiniform rash appears on second day of illness. The rash has the following characteristics:
    • Appears typically on the neck first and also chest and scapular regions. It then affects trunk and legs later.
    • Rash has a coarse texture like sandpaper. It is punctate on a diffuse erythematous base (that is pin-point dark red spots on a general reddening of the skin).
    • Circumoral pallor is evident. The area round mouth is unusually pale against surrounding flushed face. This effect is more prominent than in other fevers.
    • Rash lasts for several days but after a few days of becoming generalised it may appear more prominent in skin creases with confluent petechiae or lines (capillary fragility). This sign seen particularly in axillae and groin is Pastia's sign and the lines known as "Pastia's lines".
    • The skin may start to peel (desquamation) even during the febrile stage. This peeling which often produces flakes of skin on the face, continues for several weeks. It also affects tips of the fingers, toes, axilla, groin and ears. It is a valuable sign if patient has not been seen during febrile phase.
  • The throat may have some of the typical features described:8
    • There may be small haemorrhagic spots on palate.
    • The tonsils are often red and oedematous.
    • The tonsils may be covered with pale exudate.
    • Accompanying tender cervical lymphadenopathy is typical.
  • The tongue has a characteristic appearance which develops during the illness:9
    • Initially, during the first 2 days of the illness, patients may have a 'white strawberry tongue'. The tongue is covered by prominent red papillae seen through a white 'fur'.
    • After about 2 days the 'fur' is lost (desquamation). The tongue appears to look more raw and red, but still has prominent papillae. This is called the 'raspberry tongue' or 'red strawberry tongue'.
Differential Diagnosis2,10
Investigations
  • Throat swab and culture:
    • The most important proof of infection with 90% sensitivity for presence of group A beta-haemolytic streptococcus. However less specific as there is 10-15% carrier rate in healthy subjects.
    • It is important to take throat swabs correctly avoiding lips, tongue and buccal mucosa.
    • Swab tonsils, posterior pharynx and any exudate under good illumination.
  • Antigen detection kits:
    • Various kits are available for near patient testing. Rapid antigen tests (RATs and 'strep tests') use latex agglutination. Enzyme-linked immunosorbent assays (ELISA) are more expensive.
    • These are promoted to allow quick diagnosis and hence more appropriate administration of antibiotics. However the cost and variable sensitivity and specificity are amongst some of the reasons that use is limited.
  • Streptococcal antibody tests:
    • Proves recent infection but of no value in acute infection.
    • Has a value in patients with complications such as acute glomerulonephritis.
  • Full blood count:
    • A polymorphonuclear lymphocytosis is typical.
    • During the second week an eosinophilia may develop.
Management
  • The aims of treatment are to:
    • Shorten the illness.
    • Prevent suppurative complications (such as peritonsillar abscess formation, mastoiditis, cellulitis and ethmoiditis).
    • Reduce the risk of spread to others.
    • Prevent progression to other complications particularly rheumatic fever and glomerulonephritis.
  • Medical treatment:
    • Antibiotics. Penicillin or erythromycin if penicillin allergic are the treatments of choice given for a full 10 days.11 There are no documented penicillin-resistant group A streptococcal infections. A cephalosporin is an effective alternative to penicillin, but not if penicillin allergic.
  • Referral and other treatment:
    • Recurrent infection would be an indication for ENT referral.
    • Difficulty swallowing may necessitate hospitalisation for intravenous fluids and antibiotics.
    • Management of complications may require hospitalisation.
Complications
  • Local spread:
    • Cervical lymphadenopathy
    • Sinusitis
    • Mastoiditis
    • Peritonsillar abscess
  • Distant spread:
  • Rare, but feared, late complications include rheumatic fever (0.3%) or acute renal failure (poststreptococcal glomerulonephritis).12,13
  • Minor late sequelae:
    • Beau lines on nails
    • Telogen hair loss
Prognosis

Scarlet fever follows a benign course in vast majority of cases. Any morbidity is likely to arise from suppurative complications most often in untreated patients.

Prevention

Exclusion from school Advice is variable. Some recommend a minimum of 24 hours antibiotics before patient can return to school,2 although the HPA suggests 5 days3(may be more appropriate in nurseries where children are in closer proximity). It seems reasonable that milder cases in older children may be treated in line with other streptococcal sore throats (no specific exclusion).

Historical

Second in the historical order of classic exanthems identified:

  1. Rubeola (Measles).
  2. Scarlet Fever.
  3. Rubella (German Measles)
  4. Dukes' Disease (Coxsackie virus or Echovirus), no longer considered as a separate entity.
  5. Fifth Disease, or Erythema Infectosum (Erythrovirus, formerly parvovirus B19).
  6. Exanthem Subitum or Roseola Infantum (herpes virus, HH6).

A disease previously confused with measles, the credit for a definitive, distinctive name must go to Thomas Sydenham (1624-1689), the English Hippocrates, and the father of English medicine.


Document References
  1. Ballentine J, Scarlet Fever eMedicine 2006; Emergency medicine perspective.
  2. Dyne P; Scarlet Fever, eMedicine 2005; Paediatric perspective on Scarlet Fever
  3. Health Protection Agency (HPA) Guidelines on the Management of Communicable Diseases: Scarlet Fever (2003)
  4. Radikas R, Connolly C; Young patients in a young nation: scarlet fever in early nineteenth century rural New England. Pediatr Nurs. 2007 Jan-Feb;33(1):53-5. [abstract]
  5. Feeney KT, Dowse GK, Keil AD, et al; Epidemiological features and control of an outbreak of scarlet fever in a Perth primary school. Commun Dis Intell. 2005;29(4):386-90. [abstract]
  6. HPA; Notifiable Diseases
  7. Czarkowski MP, Kondej B; [Scarlet fever in Poland in 2003] Przegl Epidemiol. 2005;59(2):235-40. [abstract]
  8. Tewfik TL, Al Garni M; Tonsillopharyngitis: clinical highlights. J Otolaryngol. 2005 Jun;34 Suppl 1:S45-9. [abstract]
  9. Mahajan VK, Sharma NL; Scarlet Fever. Indian Pediatr. 2005 Aug;42(8):829-30.
  10. Aber C, Alvarez Connelly E, Schachner LA; Fever and rash in a child: when to worry? Pediatr Ann. 2007 Jan;36(1):30-8. [abstract]
  11. De Meyere M, Mervielde Y, Verschraegen G, et al; Effect of penicillin on the clinical course of streptococcal pharyngitis in general practice. Eur J Clin Pharmacol. 1992;43(6):581-5. [abstract]
  12. Rodriguez-Iturbe B, Batsford S; Pathogenesis of poststreptococcal glomerulonephritis a century after Clemens von Pirquet. Kidney Int. 2007 Mar 7;. [abstract]
  13. Mosquera J, Romero M, Viera N, et al; Could streptococcal erythrogenic toxin B induce inflammation prior to the development of immune complex deposits in poststreptococcal glomerulonephritis? Nephron Exp Nephrol. 2007;105(2):e41-4. Epub 2006 Nov 30. [abstract]
Acknowledgements EMIS is grateful to Dr Richard Draper for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2007.
DocID: 2750
Document Version: 20
DocRef: bgp1564
Last Updated: 22 May 2007
Review Date: 21 May 2009






















Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site














Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site


PS - Health and Poverty

Perhaps the biggest cause of ill health in the world is poverty. Help to Make Poverty History. For example, why not lend some of your money to disadvantaged communities to enable them to trade their way out of poverty through schemes such as Shared Interest.

See also MAKEPOVERTYHISTORY North East for details and links to campaigns against poverty.

^ Top of Page